NextCure Inc.

NXTC | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.31

-$0.22 (-3.30%)

At close: Oct 30, 2026, 4:00 PM ET

$6.18

-$0.13 (-2.06%)

After-hours: Oct 30, 2026, 7:35 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.30%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

35.8

+4.0 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #637/1028 (Top 62%)

Full Analysis

Key Statistics

Market Data

Market Cap $28.88M

1D Range

6.16 6.50

52W Range

1.60 14.27

Valuation (TTM)

PE -0.60

PB 2.38

EV/EBITDA -0.31

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $20.00

Cash Flow

FCF Yield -128.1%

SBC Adj. FCF Yield -133.9%

SBC Impact -4.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 37.6% | 18.8%

FCF 3Y | 5Y 10.3% | 8.7%

Returns

ROA -189.0%

ROE -175.5%

ROIC -259.9%

Financial Health

Net Cash

$19.4M

Current Ratio 3.47

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NextCure, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative immunotherapies. Its core mission is to combat cancer and various other immune-related condi...

Sector Healthcare

Industry Biotechnology

Employees 40

IPO Date May 9, 2019

Website www.nextcure.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$20.00

Upside

+216.96%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞